Maryam Zekavat (@zekavatm) 's Twitter Profile
Maryam Zekavat

@zekavatm

aka "Seyedeh Zekavat" (publication name); Harvard Ophtho Resident @MassEyeandEar; MD/PhD @Yale; Comp Bio @broadinstitute; Bioengineering @MIT; 2017 @PDSoros

ID: 3974822836

calendar_today16-10-2015 21:18:05

1,1K Tweet

716 Followers

660 Following

PD Soros Fellowships (@pdsoros) 's Twitter Profile Photo

👁️✨ Exciting research by #PDSoros Fellow Maryam Zekavat of Mass Eye and Ear! Retinal imaging isn't just about eyes – it's a crystal ball for your health! 🧬🔍 Read more in Science Translational Medicine on this eye-opening study! #HealthInSight #MedicalInnovation #ScienceWinsAn

DrZebardast (@drzebardast) 's Twitter Profile Photo

Short but incredibly rewarding trip to Seattle for #ARVO2024. Had the pleasure to share our work on #glaucoma PRS and catch up with my amazing mentees. Harvard Ophthalmology

Short but incredibly rewarding trip to Seattle for #ARVO2024. Had the pleasure to share our work on #glaucoma PRS and catch up with my amazing mentees. <a href="/HMSeye/">Harvard Ophthalmology</a>
Dr Tas Braithwaite (@tasbraithwaite) 's Twitter Profile Photo

Favourite paper ARVO yesterday. Congratulations team Harvard Maryam Zekavat DrZebardast and uk co-author Yusrah Shweikh Fulbright Scholars for a step change UK Biobank analysis on #OCT retinal thickness and systemic disease associations. Fab R visualisations! science.org/doi/abs/10.112…

Mass Eye and Ear (@masseyeandear) 's Twitter Profile Photo

Scientists Harvard Medical School & Broad Institute including Maryam Zekavat are using retinal imaging, genetics & big data to predict future eye & systemic diseases. Understanding different retinal layers could lead to targeted therapies & preventative medicine. Harvard Ophthalmology spklr.io/6018Uusy

Aoxing Liu (@aoxing2) 's Twitter Profile Photo

New out in Nature!! With age, women can lose one X chromosome in their leukocytes. What’s the cause/consequence? How does it differ from the loss of the Y chromosome in men? nature.com/articles/s4158… Broad Institute FinnGen FIMM HelsinkiUni National Cancer Institute Cambridge University

Maryam Zekavat (@zekavatm) 's Twitter Profile Photo

Our paper on Ozempic and its link to permanent vision loss through NAION in both individuals with and without diabetes was just published! massgeneralbrigham.org/en/about/newsr…

Pradeep Natarajan (@pnatarajanmd) 's Twitter Profile Photo

So far, GLP1-Ra have been linked to a myriad of beneficial effects. Now, based on clinical anecdotes then studied among 16K as a matched cohort study, Mass Eye and Ear investigators report a 7.6-fold risk of nonarteritic anterior ischemic optic neuropathy with semaglutide Rx v not

So far, GLP1-Ra have been linked to a myriad of beneficial effects. Now, based on clinical anecdotes then studied among 16K as a matched cohort study, <a href="/MassEyeAndEar/">Mass Eye and Ear</a> investigators report a 7.6-fold risk of nonarteritic anterior ischemic optic neuropathy with semaglutide Rx v not
Maryam Zekavat (@zekavatm) 's Twitter Profile Photo

Blood pressure affects your risk of glaucoma -> Here we present our paper on Independent Effects of Blood Pressure on Intraocular Pressure and Retinal Ganglion Cell Degeneration: A Mendelian Randomization Study, iovs.arvojournals.org/article.aspx?a… DrZebardast

Eric Topol (@erictopol) 's Twitter Profile Photo

We keep ignoring CHIP (clonal hematopoiesis of indeterminate potential= mutations in our blood stem cells) even though it is no longer "indeterminate." A key marker for risk of cardiovascular events and blood cancers. It should be routinely assayed in older adults.

We keep ignoring CHIP (clonal hematopoiesis of indeterminate potential= mutations in our blood stem cells) even though it is no longer "indeterminate." A key marker for risk of cardiovascular events and blood cancers. It should be routinely assayed in older adults.
David R. Liu (@davidrliu) 's Twitter Profile Photo

Last night I was honored to receive the 2025 #BreakthroughPrize in the Life Sciences, reflecting the efforts of many students, collaborators, doctors, and patients in labs around the world. I hope this 4-minute excerpt can inspire when science needs public support more than ever.

Harvard Ophthalmology (@hmseye) 's Twitter Profile Photo

Chair Dr. Joan W. Miller spoke with NBC10 Boston this week about her pioneering work developing treatments for AMD and her efforts to mentor the next generation of female leaders in ophthalmology. nbcboston.com/multimedia/cha…